About: http://data.cimple.eu/news-article/efae13118405ab8686865169d62c4e3fc228ce4df325da1ed0cb5e6d     Goto   Sponge   Distinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Hong Kong on Friday confirmed it has requested AstraZeneca suspend delivery of its Covid-19 vaccine amid fears of severe side effects and concerns over its efficacy against new variants of the coronavirus. Europe's medicines regulator said this week the AstraZeneca vaccine could cause very rare blood clots in some recipients, prompting a cascade of countries to pull the plug on giving it to people under a certain age. Britain sought Thursday to quell fears over the jab, saying the potential side effects were extremely rare -- and the risk of falling seriously sick from Covid-19 was far greater. On Friday Hong Kong's health chief Sophia Chan said the city has asked AstraZeneca not to deliver as planned later this year. "We think it is not necessary for AstraZeneca to deliver the vaccines to the city within this year," she said, adding Hong Kong wanted "to avoid any waste as vaccines are in short supply globally". Wealthy Hong Kong has already secured a good supply of vaccines for its 7.5 million residents. It has signed deals for 7.5 million shots each with BioNTech/Pfizer and China's Sinovac, both of which have begun deliveries. Chan said Hong Kong was also keen to look at other vaccines that may have stronger results against newer strains of the coronavirus. Earlier this week David Hui, a leading public health expert and government adviser, called for Hong Kong to replace AstraZeneca with a new single dose vaccine made by Johnson and Johnson. Densely populated Hong Kong was one of the first places to be hit by the coronavirus, but strict social distancing and universal mask wearing have helped keep infections to just over 11,000 with 205 deaths. While it has a steady supply of vaccines, take up has been slow amid swirling distrust of the government as Beijing cracks down on democracy supporters. So far just 529,000 people have had their first dose. Public confidence has also been hampered by government messaging. China's Sinovac received fast-track approval despite not publishing its clinical trial data in a peer reviewed journal. Administration of BioNTech's vaccine was also briefly suspended after some vials were found to be defective even though authorities said any damaged bottles were discarded before being used in vaccinations. jta/axn
schema:headline
  • Hong Kong suspends its order of AstraZeneca jabs
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software